Jak2 V617F mouse tissue histomorphological analysis is an essential preclinical tool for evaluating myeloproliferative neoplasm (MPN) phenotypes, including splenomegaly, myelofibrosis, and extramedullary hematopoiesis. This guide details the standard sample types, staining methods, pathological scoring criteria, and downstream applications for reliable morphological assessment of Jak2 V617F mutant mice. Researchers and drug developers will find practical protocols to support disease mechanism studies and therapeutic efficacy evaluation.
Technical Overview
The Janus kinase 2 (JAK2) V617F mutation is a gain-of-function somatic substitution (Valine to Phenylalanine at codon 617) within the pseudokinase domain of the JAK2 protein. This mutation is found in more than 95% of patients with polycythemia vera and in approximately 50–60% of patients with essential thrombocythemia and primary myelofibrosis. The mutation constitutively activates JAK-STAT signaling, driving uncontrolled myeloproliferation independent of cytokine stimulation.
Mouse models carrying the Jak2 V617F allele, including knock-in and transgenic constructs, faithfully recapitulate key features of human myeloproliferative neoplasms. These mice develop a phenotype dependent on mutant allele expression levels, ranging from erythrocytosis and thrombocytosis to profound myelofibrosis and splenomegaly. Histomorphological analysis of tissues from these mice is therefore a cornerstone endpoint for characterizing disease progression and evaluating the efficacy of candidate therapeutics such as JAK inhibitors, hypomethylating agents, and anti-fibrotic compounds.
Histomorphological analysis integrates macroscopic observation, routine and special histochemical staining, immunohistochemistry (IHC), and quantitative image analysis. When performed under standardized conditions, this approach yields reproducible, semi-quantitative readouts of hematopoietic disruption across the spleen, bone marrow, liver, and other affected organs.
Testing Samples
Spleen
The spleen is the most prominently affected organ in Jak2 V617F mice and is routinely collected for histology. Typical findings include marked expansion of the red pulp due to extramedullary hematopoiesis (EMH), effacement of normal white pulp architecture, increased megakaryocyte density, and clustered megakaryopoiesis. Organ weight-to-body-weight ratios should be recorded at necropsy as a complementary index of splenomegaly. Longitudinal (sagittal) sectioning through the hilum is recommended for consistent morphological comparison across treatment groups.
Bone Marrow (Femur, Tibia, and Sternum)
Bone marrow is the primary site of mutant hematopoiesis and fibrosis. Hind limbs (femur and tibia) and sternum are the standard sources. Key parameters include marrow cellularity, megakaryocyte number and morphology, lineage composition shifts, and reticulin or collagen fibrosis grade. Because decalcification can compromise antigenicity, EDTA-based decalcification is strongly preferred when IHC or specialized staining is planned on the same specimen.
Liver
The liver frequently exhibits sinusoidal infiltration by hematopoietic cells of multiple lineages, reflecting extramedullary hematopoiesis in advanced disease. Portal tract changes, sinusoidal dilatation, and iron deposition may also be documented. Hepatic EMH scoring provides a useful secondary endpoint for systemic disease burden.
Additional Tissues
- Heart and lung: evaluated for leukocyte infiltration, thrombosis, and vascular lesions associated with hyperviscosity or elevated platelet counts.
- Kidney: assessed for glomerular and vascular pathology secondary to hematological abnormalities.
- Lymph nodes and thymus: examined when immune perturbation or extramedullary hematopoiesis is suspected.
- Blood smears: optional but valuable for correlating morphology with complete blood count data.
Testing Items
A comprehensive histomorphological panel for Jak2 V617F mouse tissues typically includes the following readouts:
- Hematoxylin and eosin (H&E) staining for general morphology of all collected tissues.
- Reticulin fiber staining (Gordon-Sweets or equivalent silver-based method) for bone marrow and splenic fibrosis grading.
- Masson's trichrome or Sirius Red staining for collagen deposition in advanced fibrosis.
- Perls' Prussian blue staining for iron burden in spleen, liver, and bone marrow.
- Immunohistochemistry for lineage markers, including CD41 or CD42b for megakaryocytes, Ter119 for erythroid cells, Ly6G or MPO for granulocytes, Mac-2 or CD68 for macrophages, and CD3/B220 for lymphoid compartments.
- Immunohistochemistry or immunofluorescence for phospho-STAT5 and phospho-STAT3 to confirm downstream JAK-STAT pathway activation.
- Quantitative image analysis of megakaryocyte density, marrow cellularity percentage, fibrosis area fraction, and splenic red pulp expansion.
- Semi-quantitative fibrosis scoring using the adapted European consensus grading scale (MF-0 through MF-3) for murine marrow.
Testing Methods
Tissue Collection and Fixation
Animals are euthanized according to approved institutional protocols, and tissues are harvested immediately to minimize autolysis. Spleen and liver are weighed before fixation. Bone-containing specimens are fixed in 10% neutral buffered formalin for 24 to 48 hours. Bouin's fixative may be used for small bone specimens to improve decalcification quality. Adequate fixation time is critical for preserving megakaryocyte cytological detail and reticulin fiber integrity.
Decalcification and Processing
Femurs, tibias, and sternae are decalcified using 10–14% EDTA solution at a neutral pH with gentle agitation, with solution changes every 2 to 3 days over approximately 7 to 14 days depending on specimen size. EDTA decalcification preserves enzymatic and antigenic reactivity better than strong acid methods. Following decalcification, tissues are dehydrated through graded alcohols, cleared, and embedded in paraffin with careful orientation to obtain longitudinal marrow sections of maximal diagnostic value.
Sectioning and Staining
Paraffin blocks are sectioned at 3 to 5 micrometers. H&E staining follows standard automated protocols. Reticulin staining is performed on marrow and spleen sections with careful silver impregnation and toning to visualize fine fiber networks. IHC is performed using heat-induced epitope retrieval (citrate or EDTA buffer, pH 6.0 or 9.0) optimized for each antibody, with appropriate positive and negative controls included in every run.
Morphological Evaluation and Scoring
Slides are evaluated by a veterinary or experimental pathologist blinded to treatment group when possible. Bone marrow fibrosis is graded on an adapted four-tier scale: MF-0 (normal reticulin network), MF-1 (loose network of reticulin fibers, focally increased), MF-2 (diffuse and dense increase with crosslinks), and MF-3 (diffuse dense increase with extensive collangenization). Megakaryocyte counts are performed per high-power field in defined marrow regions, and clustering is documented as present or absent. Splenic red pulp and white pulp proportions are estimated, and hepatic EMH is scored by sinusoidal hematopoietic cell density.
Quantitative Image Analysis
Digital whole-slide scanning enables reproducible quantification. Standard metrics include percentage marrow cellularity, reticulin-positive area fraction, megakaryocytes per square millimeter, and IHC-positive area or cell counts using validated analysis software. Batch analysis with identical thresholding parameters across treatment groups minimizes operator bias and strengthens statistical power.
Applications
- Preclinical efficacy testing of JAK inhibitors, such as ruxolitinib and fedratinib analogs, using spleen weight reduction and fibrosis improvement as primary endpoints.
- Longitudinal natural history studies characterizing the transition from polycythemic early disease to myelofibrotic late-stage disease.
- Evaluation of anti-fibrotic, anti-inflammatory, and epigenetic therapeutic strategies targeting the tumor microenvironment.
- Investigation of clonal evolution, disease acceleration, and leukemic transformation in combination with genetically modified backgrounds.
- Biomarker discovery linking tissue-level pathology with peripheral blood parameters and molecular readouts such as mutant allele burden.
- Support for IND-enabling toxicology packages where hematopoietic organ pathology must be characterized in detail.
FAQ
Why is EDTA decalcification recommended instead of acid decalcification?
EDTA is a chelating agent that removes calcium gradually while preserving nucleic acids, protein antigens, and tissue morphology. Strong acid decalcification is faster but damages reticulin fibers and destroys most epitopes required for IHC, including megakaryocyte and lineage markers. For studies where both special stains and immunohistochemistry are planned on bone marrow, EDTA is the standard choice.
How is myelofibrosis graded in mice?
Murine myelofibrosis is typically graded using the European consensus scale adapted for mice, ranging from MF-0 to MF-3 based on reticulin fiber density, thickness, and collagen deposition in bone marrow sections. Scoring should be performed on standardized anatomical regions of longitudinally sectioned femur or sternum, ideally by a blinded pathologist, and complemented by quantitative image analysis for objective group comparisons.
Which tissues are the minimum required set for a typical efficacy study?
At minimum, spleen, femur or tibia bone marrow, and liver should be collected with H&E and reticulin staining. Adding sternum provides a second independent marrow compartment, and blood smears with CBC data allow correlation of tissue morphology with hematological phenotypes. Expanded panels including heart, lung, and kidney are advisable for longer-term or toxicity-oriented studies.
How many animals per group are recommended for histomorphological analysis?
A minimum of 5 to 8 animals per group is generally recommended for semi-quantitative scoring studies, as fibrosis grades and EMH scores are categorical variables with limited dynamic range. For quantitative image analysis endpoints, similar group sizes typically provide adequate power, but exact numbers should be justified by power analysis based on pilot data and expected effect sizes.
Can immunohistochemistry be combined with special stains on the same specimen?
Yes. Serial sections from the same paraffin block allow H&E, reticulin, trichrome, and IHC staining of immediately adjacent tissue planes. This approach enables direct correlation of fibrosis grade with lineage composition and signaling pathway activation status within the same anatomical region, substantially improving interpretive confidence.